+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
HSV 1 Keratitis - Pipeline Insight, 2026 - Product Thumbnail Image

HSV 1 Keratitis - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 60 Pages
  • Global
From
From
COSENTYX Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

COSENTYX Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Huntington'S Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Huntington'S Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 80 Pages
  • Global
From
Fenebrutinib Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Fenebrutinib Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
JORVEZA Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

JORVEZA Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
From
CNM-Au8 Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

CNM-Au8 Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
Bedaquiline Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Bedaquiline Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
OCREVUS Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

OCREVUS Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
Asthma - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Asthma - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
From
From
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 400 Pages
  • Global
From
HSV-1 Keratitis - Competitive Landscape, 2026 - Product Thumbnail Image

HSV-1 Keratitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 60 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Glaucoma - Competitive Landscape, 2026 - Product Thumbnail Image

Glaucoma - Competitive Landscape, 2026

  • Report
  • January 2026
  • 280 Pages
  • Global
From
Chronic Kidney Disease - Competitive Landscape, 2026 - Product Thumbnail Image

Chronic Kidney Disease - Competitive Landscape, 2026

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more